Publikasjoner

Her finner du gruppens utvalgte publikasjoner.

Ringstad IB, Skovlund E, Roa Santervas L, Kersten H, Fjeld KG, Hove LH, Wyller TB, Jensen JL, Romskaug R. Association Between Anticholinergic Burden and Dry Mouth Severity in Acutely Ill Older Adults. Drugs Aging 2026. Epub ahead of print.
Roa Santervas L, Skovlund E, Kristoffersen ES, Ringstad IB, Fjeld KG, Hove LH, Jensen JL, Wyller TB, Romskaug R. Collaborative medication reviews during acute primary care admissions for older adults with polypharmacy: a randomised controlled trial. Age Ageing 2026; 1;55(2):afag029.
Kersten H, Barca ML, Eldholm RS, Persson K, Thomasgaard L, Jaioun K, Saltvedt I, Selbaek G, Engedal K. Potentially inappropriate medications related to two-year progression of mild cognitive impairment and dementia. Eur J Clin Pharmacol. 2026; 82(2):45.
López-Toribio M, Dalleur O, Adda TR, De Saint-Hubert M, Dikeos D, Tsoutsi V, Callegari E, Wyller TB, Wichniak A, Kaznowski M, Miralles R, Pascual B, Fernández-Maldonado L, Aubert CE, Mooser B, Bolt L, Grimshaw J, Spinewine A, Macq J. Mapping care trajectories for hospital-initiated benzodiazepine deprescribing in older adults: a multicentre qualitative study. BMC Health Serv Res 2025; 25(1):1578.
Ringstad IB, Romskaug R, Santervas LR, Fjeld KG, Hove LH, Skovlund E, Wyller TB, Jensen JL. Oral Health, Xerogenic Medications, and Frailty in Acutely Ill Older Adults. J Am Geriatr Soc 2025; 73(8):2466-2474.
Roa Santervas L, Wyller TB, Skovlund E, Kristoffersen ES, Romskaug R. Associations Between Frailty, Illness Severity, and Long-Term Mortality Among Older Adults Admitted to Municipal Acute Care. J Am Med Dir Assoc 2025; 26(8):105718.
Shapoval V, de Saint Hubert M, Pétein C, Viaud C, Adda T, Aubert CE, Mooser B, Tsoutsi V, Dikeos D, Maldonado LF, Castejon JMP, Wichniak A, Gustavsson K, Wyller TB, Callegari E, Grimshaw J, Presseau J, Patey A, Corachan S, Henrard S, Spinewine A. Barriers to discontinuing benzodiazepine receptor agonists in older adults: a survey of older adults across Europe. Age Ageing 2025; 54(12):afaf342.
Syversen MO, Glatkauskas M, Sedeniussen SJ, Hauge M, Benny S, Horgen K, Lea M, Romskaug R, Njaastad AM, Wibe T, Svensberg K, Mathiesen L. Discrepancies in medication lists after hospital discharge in patients with multiple long-term conditions. Res Social Adm Pharm 2025; 21(8):580-588.
Shapoval V, de Saint Hubert M, Evrard P, Sibille FX, Aubert CE, Bolt L, Tsoutsi V, Kollia P, Salvà A, Miralles R, Wichniak A, Gustavsson K, Bruun Wyller T, Callegari E, Grimshaw JM, Presseau J, Henrard S, Spinewine A. Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians. JAMA Netw Open 2025; 8(3):e2459883.
Veddeng S, Madland H, Molden E, Wyller TB, Romskaug R. Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study. BMC Geriatr 2022; 22: 242.
Callegari E, Benth JS, Selbæk G, Grønnerød C, Begh S. Do prescription rates of psychotropic drugs change over three years from nursing home admission? BMC Geriatr 2021; 16;21(1):496.
Cheng S, Siddiqui TG, Gossop M, Wyller TB, Kristoffersen ES, Lundqvist C. The patterns and burden of multimorbidity in geriatric patients with prolonged use of addictive medications. Aging Clin Exp Res 2021; 33(10):2857-2864.
Romskaug R, Skovlund E, Straand J, Molden E, Kersten H, Pitkala KH, Lundqvist C, Wyller TB. Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients peceiving polypharmacy: a cluster randomized clinical trial. JAMA Intern Med 2020; 180: 181-9.
Romskaug R, Wyller TB, Straand J, Kersten H, Molden E. Prescribed doses of CYP2D6-metabolized drugs and hemodynamic responses in relation to CYP2D6 genotype among older patients exposed to polypharmacy. Drugs Aging 2020; 37: 425-33.

Publisert 19. mars 2026 20:42 - Sist endret 19. mars 2026 20:58